Email Alert | RSS

Journal of Tuberculosis and Lung Disease ›› 2024, Vol. 5 ›› Issue (4): 352-357.doi: 10.19983/j.issn.2096-8493.2024053

• Review Articles • Previous Articles     Next Articles

Progress in tuberculosis infection screening, diagnosis and treatment of female infertility patients before in vitro fertilization-embryo transfer

Li Yabo1, Fan Lijuan2, Sun Xiuli1, Gou Liangzhi1, Ren Beiying1, Shi Juanzi2, Wang Fang3, Ma Xiaoling4, Xie Yonghong5, Liu Xin1, Wu Qianhong6()   

  1. 1Department of Gynecology, Shaanxi Provincial Tuberculosis Prevention and Control Hospital, Xi’an 710100, China
    2Department of Reproduction, Northwest Women and Children’s Hospital, Xi’an 710061, China
    3Reproductive Center, the Second Affiliated Hospital of Lanzhou University, Lanzhou 730030, China
    4Reproductive Center, the First Affiliated Hospital of Lanzhou University, Lanzhou 730000, China
    5Department of Respiratory Medicine, Air Force Medical University, Xi’an 710032, China
    6Department of Geriatrics, the Second People’s Hospital of Shaanxi Province (Shaanxi Province Geriatric Hospital), Xi’an 710005, China
  • Received:2024-03-18 Online:2024-08-20 Published:2024-08-13
  • Contact: Wu Qianhong E-mail:15902969531@126.com
  • Supported by:
    Xi’an Science and Technology Bureau Xi’an Finance Bureau Fund(22YXYJ0160)

Abstract:

In vitro fertilization-embryo transfer (IVF-ET) is an effective method for treating female infertility. During IVE-ET course, patients with female reproductive system tuberculosis have certain risk of activating tuberculosis to recurrent, which leads to low success rate of IVF-ET and high incidence of adverse events. In China, large number of patients have active tuberculosis disease or tuberculosis latent infection. Screening for tuberculosis infection before IVF-ET in infertile women and then taking necessary intervention can improve the success rate of IVF-ET and reduce the incidence of adverse events. At present, there is no conclusion on standard treatment before IVE-ET for infertile women with female reproductive system tuberculosis infection. This article reviews the application of laboratory, imaging, endoscopic, and pathological examination and anti-tuberculosis treatment in screening, diagnosis and treatment of female reproductive system tuberculosis infection, in order to provide clinical reference for the screening and treatment of tuberculosis infection in infertile women before IVF-ET.

Key words: Tuberculosis, Fertilization in vitro, Embryo transfer, Diagnosis, Therapeutics

CLC Number: